These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1353239)

  • 1. Sustained haematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes.
    Kelsey SM; Newland AC; Cunningham J; Makin HL; Coldwell RD; Mills MJ; Grant IR
    Lancet; 1992 Aug; 340(8814):316-7. PubMed ID: 1353239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndrome with alfacalcidol].
    Tagawa M; Ito H; Kuriyama K; Tomonaga M; Ichimaru M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3160-2. PubMed ID: 3674901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders].
    Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T
    Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic trial of hematological disorders with intermittent administration of high-dose 1-alpha-hydroxyvitamin D3.
    Imai Y; Tsutsumi M; Tsunenari T; Nishikawa M; Matsui T; Natazuka T; Fujita T
    Contrib Nephrol; 1991; 91():95-101. PubMed ID: 1800016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study.
    Yoshida Y; Oguma S; Uchino H; Maekawa T; Nomura T
    Int J Clin Pharmacol Res; 1993; 13(1):21-7. PubMed ID: 8509233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes.
    Akiyama N; Miyazawa K; Kanda Y; Tohyama K; Omine M; Mitani K; Ohyashiki K
    Leuk Res; 2010 Sep; 34(9):1151-7. PubMed ID: 20569983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic benefits of 1-hydroxyvitamin D3 in an elderly patient with chronic myelodysplastic syndrome.
    Motomura S; Fujisawa S; Tsunooka S; Fujimaki K; Mohri H; Okubo T
    Am J Hematol; 1996 Oct; 53(2):143-4. PubMed ID: 8892744
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 (1 alpha(OH)D3)].
    Taoka T; Hamamoto T; Okuda Y; Hata Y; Kubota Y; Tanaka T; Irino S; Miyazaki T; Ohbayashi S
    Rinsho Ketsueki; 1987 Jun; 28(6):830-8. PubMed ID: 3478504
    [No Abstract]   [Full Text] [Related]  

  • 9. Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial.
    Komrokji R; Garcia-Manero G; Ades L; Prebet T; Steensma DP; Jurcic JG; Sekeres MA; Berdeja J; Savona MR; Beyne-Rauzy O; Stamatoullas A; DeZern AE; Delaunay J; Borthakur G; Rifkin R; Boyd TE; Laadem A; Vo B; Zhang J; Puccio-Pick M; Attie KM; Fenaux P; List AF
    Lancet Haematol; 2018 Feb; 5(2):e63-e72. PubMed ID: 29331635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose alfacalcidol improves anaemia in patients on haemodialysis.
    Albitar S; Genin R; Fen-Chong M; Serveaux MO; Schohn D; Chuet C
    Nephrol Dial Transplant; 1997 Mar; 12(3):514-8. PubMed ID: 9075133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended dose of alfacacidol for osteoporosis.
    Bunyaratavej N
    J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S7-9. PubMed ID: 22338919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of intermittent versus continuous oral alfacalcidol treatment of hyperparathyroidism in end-stage renal disease.
    Tarrass F; Yazidi A; Sif H; Zamd M; Benghanem MG; Ramdani B
    Clin Nephrol; 2006 Jun; 65(6):415-8. PubMed ID: 16792136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H
    Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
    Omori-Mizuno Y; Nakayama N; Inao M; Funyu J; Asabe S; Tomita K; Nishikawa K; Hosoda Y; Tanaka M; Hashimoto Y; Yakabi K; Koshima Y; Mochida S
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1384-90. PubMed ID: 25778685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease.
    Zold E; Szodoray P; Nakken B; Barath S; Kappelmayer J; Csathy L; Hajas A; Sipka S; Gyimesi E; Gaal J; Barta Z; Hallay J; Szegedi G; Bodolay E
    Autoimmun Rev; 2011 Jan; 10(3):155-62. PubMed ID: 20868777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial comparing pulse calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism in haemodialysis patients.
    Kiattisunthorn K; Wutyam K; Indranoi A; Vasuvattakul S
    Nephrology (Carlton); 2011 Mar; 16(3):277-84. PubMed ID: 21342321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The assessment of cynacalcet (Mimpara) accompanied by alfacalcidol treatment efficacy in haemodialysis patients with different secondary hyperparathyroidism severity recognized by iPTH].
    Zwiech R; Dryja P; Łacina D; Nykiel P; Sek-Szczepanowska K; Bratkowska K; Pietrzak B; Chrul S
    Wiad Lek; 2011; 64(4):267-73. PubMed ID: 22533150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1α-Calcidol (Alfacalcidol) on Microvascular Endothelial Function, Arterial Stiffness, and Blood Pressure in Type II Diabetic Nephropathy Patients.
    Munisamy S; Daud KM; Mokhtar SS; Rasool AH
    Microcirculation; 2016 Jan; 23(1):53-61. PubMed ID: 26749451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose cytarabine therapy in myelodysplastic syndromes.
    el-Mangoush M; Singh NK
    J Assoc Physicians India; 1992 Jul; 40(7):452-4. PubMed ID: 1484026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.